Compare CABA & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABA | FLXS |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.1M | 327.6M |
| IPO Year | 2019 | 1995 |
| Metric | CABA | FLXS |
|---|---|---|
| Price | $1.48 | $74.70 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | $11.75 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 4.9M | 55.5K |
| Earning Date | 11-05-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 1.38% |
| EPS Growth | 10.26 | ★ 70.99 |
| EPS | N/A | ★ 1.24 |
| Revenue | N/A | ★ $459,178,000.00 |
| Revenue This Year | N/A | $3.48 |
| Revenue Next Year | N/A | $5.29 |
| P/E Ratio | ★ N/A | $58.87 |
| Revenue Growth | N/A | ★ 4.10 |
| 52 Week Low | $1.18 | $34.59 |
| 52 Week High | $4.23 | $90.65 |
| Indicator | CABA | FLXS |
|---|---|---|
| Relative Strength Index (RSI) | 41.97 | 44.26 |
| Support Level | N/A | $68.68 |
| Resistance Level | $1.63 | $78.44 |
| Average True Range (ATR) | 0.14 | 3.82 |
| MACD | 0.04 | -0.19 |
| Stochastic Oscillator | 63.33 | 50.84 |
Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.